Results 111 to 120 of about 2,003 (162)

Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model. [PDF]

JBMR Plus
Cacco T, Papa R, Carmisciano L, Bruzzo C, Semino L, Tonelli A, Matucci-Cerinic C, Di Rocco M, Bocciardi R, Gattorno M, D'Agostino R.   +10 more
europepmc   +1 more source

Advancements in mechanisms and drug treatments for fibrodysplasia ossificans progressiva. [PDF]

J Zhejiang Univ Sci B
Zhou Y, Shi C, Sun H.
europepmc   +1 more source

Palovarotene (Sohonos), a synthetic retinoid for reducing new heterotopic ossification in fibrodysplasia ossificans progressiva: history, present, and future. [PDF]

JBMR Plus
Hsiao EC, Pacifici M.
europepmc   +1 more source

Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva. [PDF]

Biomedicines
Mejias Rivera L, Shore EM, Mourkioti F.
europepmc   +1 more source

Early Detection for Better Patient Outcome: A Case Report on Two Patients Presenting With Fibrodysplasia Ossificans Progressiva at Tikur Anbessa Specialized Hospital, Ethiopia. [PDF]

Case Rep Orthop
Haile AM, Azale AW, Ayana B.
europepmc   +1 more source

Actionable disease insights from bedside-to-bench investigation in fibrodysplasia ossificans progressiva. [PDF]

J Bone Miner Res
Wein MN, Yang Y.
europepmc   +1 more source

Fibrodysplasia ossificans progressiva.

Indian pediatrics, 2006
Vedavati, Subramanyam, So, Shivbalan
openaire   +1 more source